Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)
Recruiting now
Conditions studied: Hemostasis
In brief
The PFA (platelet function analysis) test is prescribed for the exploration of primary hemostasis and the study of platelet-willebrand factor interaction. It is performed using citrated blood, with technical difficulties and frequent alarms that may be linked to the choice of anticoagulant (citrate). It is proposed to compare the results obtained with a conventional citrate tube and a BAPA tube, which is an anticoagulant used in clinical research and which blocks coagulation by another mechanism that would have less impact on blood platelets.
Key facts
- Study ID
- NCT06753838
- Run by
- Centre Hospitalier Universitaire Dijon
- People needed
- 100
- Starts
- 2025-01-21
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2025-09-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Person having given their non-opposition
- Person of legal age
- Person receiving a haemostasis consultation at the haemophilia and haemorrhagic diseases treatment center followed by a blood sample with a PFA test prescribed by the doctor (the test is not added for the study).
You may not qualify if…
- persons under legal protection (curatorship, guardianship)
- persons subject to a court protection order
- pregnant, parturient or breast-feeding women
- adult incapable or unable to give consent
- minor
Where it is running
- CHU Dijon Bourgogne — Dijon, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.